drugset / Trial / NCT01265524
Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine the effects of CLP on serum potassium and signs and symptoms of fluid overload in heart failure patients with chronic kidney disease.
Timeline
- Start
- 2011-04
- Primary completion
- 2011-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CLP | Unknown | 15 g | Oral |